Comparison of the efficacy of immunosuppressive regimens on orthotopic heart allografts.
D000284:Administration, Oral; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D003429:Cross Reactions; D003520:Cyclophosphamide / Q000008:administration & dosage; D004176:Dipyridamole / Q000008:administration & dosage; D004285:Dogs; D006084:Graft Rejection; D016027:Heart Transplantation; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000401:mortality; D011239:Prednisolone / Q000008:administration & dosage; D013934:Thymectomy; D013997:Time Factors; D014184:Transplantation, Homologous
D000906:Antibodies; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D004176:Dipyridamole; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine